Table 4.
Alkaloid nanoformulations for treatment of lung cancer.
| Alkaloidal anticancer drug | Nanoformulation type | Type of study | Model used | Reference |
|---|---|---|---|---|
| Docetaxel | Liposome | In vivo | A549 xenograft rat | (221) |
| In vitro | A549 cell lines | (222) | ||
| In vitro | A549 cell lines | (223) | ||
| Micelle | In vitro | A549 cell lines | (224) | |
| Nanostructured lipid carrier | In vitro | A549 cell lines | (225) | |
| Nano-extraction | In vitro | A549 cell lines | (226) | |
| Paclitaxel | Liposome | In vivo | A549 xenograft mice | (227) |
| In vitro | A549 cell lines | (228) | ||
| In vivo | Mice, mouse | (229) | ||
| Polymeric micelles | In vivo | Rats | (230) | |
| SLN | In vivo | Mice | (231) | |
| In vitro | MXT-B2 cell lines | (231) | ||
| Topotecan | Liposome | In vitro | LLC | (232) |
| Berberine | SLN | In vitro | A549 cell lines | (233) |
| Evodiamine of fructus bruceae oil | Nanoemulsions | In vivo | Rats and mice | (234) |
| Vinblastine | Cationic liposome | In vitro | LLT cells | (235) |
| Cationic liposome | In vivo | C57BL/6 mice | (235) | |
| Irinotecan | Liposome | In vivo | Xenograft mouse | (236) |
| 9-nitro camptothecin | Liposome | In vivo | Mice | (237) |
| β-carboline and quinazoline alkaloids | Platinum and Palladium Nanoparticles | In vitro | A549 cell lines | (238) |
| Alkaloid extract from Derris trifoliata | Silver nanoparticles | In vitro | A549 cell lines | (239) |
| Alkaloid extract from Justicia adhatoda | Gold nanoparticles | In vitro | A549 cell lines | (240) |
| Alkaloid extract from Indigofera tinctoria | Silver and gold nanoparticles | In vitro | A549 cell lines | (241). |